Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: L423PRV3V3

Structure

InChI Key JZCWLJDSIRUGIN-UHFFFAOYSA-N
Smile CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1
InChI
InChI=1S/C24H25N5O3S/c1-15(2)33(30,31)19-10-8-18(9-11-19)21-14-27-24(25)23(28-21)22-12-20(29-32-22)17-6-4-16(5-7-17)13-26-3/h4-12,14-15,26H,13H2,1-3H3,(H2,25,27)

Physicochemical Descriptors

Property Name Value
Molecular Formula C24H25N5O3S
Molecular Weight 463.56
AlogP 3.95
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 7.0
Polar Surface Area 124.0
Molecular species BASE
Aromatic Rings 4.0
Heavy Atoms 33.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Serine-protein kinase ATR inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Ovarian Neoplasms 2 D010051 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Leiomyosarcoma 2 D007890 ClinicalTrials
Fallopian Tube Neoplasms 2 D005185 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Small Cell Lung Carcinoma 2 D055752 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 1 D000077195 ClinicalTrials
Uterine Cervical Neoplasms 1 D002583 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 1 D002289 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 1 D000077195 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 1 D000077195 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 1 D000077195 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 131166
ChEMBL CHEMBL3989870
DrugBank DB11794
FDA SRS L423PRV3V3
Guide to Pharmacology 8003
PubChem 59472121
SureChEMBL SCHEMBL3061890
ZINC ZINC000096170459